Webinar Registration: The new health system supply chain mandate: What every SAM needs to know

October 8, 2020 10:00 AM - 11:00 AM  Central Time (US and Canada)

Covid-19 has painfully illuminated the healthcare supply chain’s multiple fissures and failure points. Despite numerous heroic efforts from IDNs, suppliers and distributors, too many organizations are still struggling to maintain adequate levels of PPE, essential pharmaceuticals and diagnostic testing supplies.

The silver lining: Leaders across the healthcare ecosystem recognize that the entire supply chain must evolve to become more agile and resilient. But given health systems’ precarious finances, the supply chain must evolve in ways that do not significantly increase costs.

Despite government officials’ talk of increased stockpiles and domestic manufacturing, the sustainable solution requires greater transparency across all parts of the supply chain. To deliver on this promise of increased visibility, suppliers must transform their approach to value messaging, data sharing, collaboration and strategic customer engagement.

Join Brandi Greenberg, Vice President of Advisory Board’s life sciences and healthcare ecosystem research team, as she reviews the most salient insights emerging from Advisory Board’s exploration into what it will take to enable a more modern and resilient healthcare supply chain.

In this webinar, attendees will learn:
     • How the new supply chain resiliency mandates are impacting health system purchasing priorities, inventory requirements and vendor expectations
     • How health system executives across finance, operations, strategy and purchasing are working together to mitigate supply chain risk
     • How progressive health systems are creating new roles, leveraging data and establishing new partnerships to enhance supply-chain visibility and resilience
     • How SAMs can build trust to enable the kinds of collaborative relationships and service models necessary for long-term success




Brandi is currently Advisory Board’s Vice President of Life Sciences and Health Care Ecosystem Research. In this capacity, she oversees all of Advisory Board’s research, training, and interactive experiences for life sciences and digital health companies’ medical, commercial, and L&D teams. She assumed this position in early 2019, after devoting 14+ years to building out Advisory Board’s “customer insight” research subscription for commercial leaders of life sciences, digital health, and health care services firms.

In Fall 2018, her team launched the Medical Affairs Leadership Council— a subscription research membership designed to help medical and HEOR executives (from pharma and device) create more compelling, impactful medical value narratives for payers and HCPs. Prior to that work, she launched the firm’s Sales Transformation Support Initiative to help suppliers’ strategic accounts teams engage with health system leaders more effectively. After writing Twelve Surprising Truths about Engaging Hospital Purchasers and What Your Hospital Customers Really Want, Brandi has become a sought-after speaker on customer value frameworks, provider-supplier partnerships, IDN purchasing trends, and outcomes-based contracts. 

While leading Advisory Board’s research for life sciences, Brandi also helped to launch constituency-based research subscriptions for health services firms, independent physician groups, and post-acute care providers. Across all these research memberships—including Advisory Board’s newest offering for leaders of US medical affairs and HEOR teams—Brandi’s goal has been the same: to share the insights and best practices that make it easier for health care organizations to understand each other’s perspectives, find common ground, and work more effectively together.

Prior to work at Advisory Board, Brandi was a Practice Manager with the Los Angeles office of the Boston Consulting Group. While at BCG, she supported clients in the biopharmaceutical, medical device, and health care delivery sectors. She has led major organizational redesign efforts to improve drug commercialization, clinical trials management, and operating room efficiency.

Brandi received her MBA from the Stanford Graduate School of Business, where she graduated as an Arjay Miller scholar. She also holds an MA in Rhetoric from Duke University and an AB with honors in English and
American Studies from Stanford University.

Please fill out the form below to register for this webinar.